Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth: A Multicentre, Randomized Study (AUTOP 2)

NCT06349122 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT06349122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06349122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth: A Multicentre, Randomized Study (AUTOP 2)
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
June 30, 2029
Enrollment
1,794 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis, premature delivery, vaginal dysbiosis